ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,844, issued on July 1, was assigned to LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (List) (Esch/Alzette, Luxembourg).
"DNA aptamers specific of adenovirus types" was invented by Leslie Ogorzaly (Ay-sur-Moselle, France), Samuel Jourdan (Aubange-Battincourt, Belgium) and Catherine Mulholland (Antrim, Ireland).
According to the abstract* released by the U.S. Patent & Trademark Office: "A single stranded nucleic acid aptamer able to specifically bind to at least one Adenovirus type, the aptamer comprising or consisting of one of sequences SEQ ID NO:1 to 3, or variants thereof having at least 50% sequence identity. Additionally, a composition comprising the aptamer. Furthermore, use...